NCT00020124View on ClinicalTrials.gov

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Study Completion Date

December 31, 2002

Conditions
Lung CancerMalignant MesotheliomaMetastatic Cancer
Interventions
DRUG

doxorubicin hydrochloride

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00020124 - Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs | Biotech Hunter | Biotech Hunter